Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin thickness measurements during topical pimecrolimus and corticosteroid therapy
2011-004953-17Phase 2Completed
- Sponsor
- Technische Universität Dresden
- Start
- Dec 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pimecrolimus, hydrocortisone, Betacap, methylprednisolone aceponate and Dermatop Basecreme in atopic dermatitis (AD) (6 arms), sponsored by Technische Universität Dresden. Started Dec 2011; status: completed.
02
Drugs
pimecrolimushydrocortisoneBetacapmethylprednisolone aceponateDermatop Basecreme
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2011-004953-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004953-17.